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Women’s  imaging:  From  symptom  to
diagnosisImaging  plays  a  fundamental  role  in  screening  and  early  depiction  of  a  variety  of  can-
cers.  In  this  regard,  breast  cancer  is  undoubtedly  emblematic  [1]. In  women,  imaging
substantially  contributes  to  the  staging  of  uterine,  ovarian  and  breast  cancers.  Imaging
has  a  direct  role  in  the  treatment  of  breast  or  pelvic  diseases  including  ablation  of  breast
tumors,  ﬁbroid  embolization,  emergency  treatment  of  postpartum  hemorrhage  or  opening
of  Fallopian  tube  to  treat  infertility.
On  a  daily  basis,  however,  in  each  radiology  suite,  clinic  and  hospital,  the  main  role  of
imaging  is  to  help  answer  the  fundamental  question:  ‘‘What  disease  explains  my  patient’s
clinical  complaint,  symptom  or  sign  on  examination?’’
Undoubtedly  the  aim  of  modern  medicine  is  to  prevent  development  of  the  symptom
by  avoiding  the  disease  or  allowing  it  to  be  diagnosed  early  before  clinical  signs  develop,
in  gynecology  with  prevention  of  cervical  cancer  by  vaccination  or  screening  for  cervical
cancer  with  a  cervical  smear  or  for  breast  cancer  with  mammography.  The  normal
woman  is  asymptomatic  although  clearly  a  large  number  of  breast  or  cervical  cancers  are
diagnosed  at  the  clinical  stage.  Almost  all  benign  breast  and  pelvic  diseases,  which  require
at  least  reassurance  if  not  treatment  also  present  with  a  clinical  complaint.  The  symptom
is  therefore  the  overt  manifestation  of  an  underlying  morbid  process,  which  needs  to  be
identiﬁed.  Imaging  has  a  considerable  place  in  this  diagnostic  process.  It  must  be  tailored
to  the  severity  and  recent  or  non-recent  nature  of  the  symptom,  the  results  of  clinical
examination  and  also  particularly  to  the  epidemiological  context,  an  essential  factor  in
disease  prevalence.  As  an  example  in  the  ﬁeld  of  pelvic  pain,  the  possible  diagnoses  and
therefore  algorithms  differ  depending  on  whether  the  pain  is  acute  or  chronic,  whether
it  is  present  in  a  woman  of  childbearing  age  or  a  postmenopausal  woman  and  whether  or
not  the  woman  has  a  history  of  recent  pelvic  surgery.
A  symptom  does  not  mean  cancer  in  breast  disease  as  in  other  situations.  Cancer,  how-
ever,  causes  fear  [1,2]. According  to  the  survey  published  by  the  ARC  foundation,  57%  of
French  people  questioned  listed  cancer  as  the  most  feared  disease  and  72%  of  them  con-
sidered  that  they  were  likely  to  suffer  cancer  during  their  lives.  Even  the  most  serious
websites  inform  and  worry.  The  INCa  site  for  example  rightly  recommends  a  consultation
for  a  lump  in  the  breast,  change  in  breast  or  nipple  skin,  lymph  nodes  in  the  axillar  or
a  change  in  size  or  shape  of  the  breast.  Whilst  these  symptoms  may  indicate  aggressive
cancer,  which  requires  urgent  care,  they  are  usually  due  to  a  benign  disease.  Here  again,
imaging  lies  at  the  heart  of  the  diagnostic  approach.
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Because,  for  each  symptom  the  ever-quoted  ‘underly-
ng  morbid  process’  needs  to  be  investigated,  because  the
iagnostic  process  is  largely  based  on  imaging  and  because
iopsies  are  not  performed  just  anywhere,  any  way  or
t  any  time,  the  SIFEM  has  designed  this  issue  of  Diag-
ostic  and  Interventional  Imaging,  which  is  intended  to
e  both  exhaustive  in  terms  of  the  diagnostic  possibilities
nd  appearances  in  imaging  and  a  summary  of  diagnostic
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